Dr Siddhartha Dutta

 Pharmacology

Dr. Siddhartha Dutta

Assistant Professor

MBBS, MD, DNB(Gold Medalist), MNAMS

 

     

     

    1. Research publications:

     

    1. Singh M, Sinha BP, Dutta S, Deokar KK, Mishra D, Goswami K . A Systematic Review and Meta-Analysis on the Efficacy and Safety of Topical Pilocarpine 1.25% in Presbyopia Treatment. Journal of Current Ophthalmology 36(2): Apr–Jun 2024;p 111-121. [Impact Factor: 1.2]
    2. Dholariya S, Dutta S, Sonagra A, Kaliya M, Singh R, Parchwani D, Motiani A. Unveiling the utility of artificial intelligence for prediction, diagnosis, and progression of diabetic kidney disease: an evidence-based systematic review and meta-analysis. Curr Med Res Opin. 2024 Nov 13:1-31. doi: 10.1080/03007995.2024.2423737. [Impact Factor: 2.4]
    3. Singhal S, Shah RB, Bansal S, Dutta S. Doctor–patient communication practices: A cross-sectional survey on Indian physicians. Journal of Family Medicine and Primary Care 13(11):p 5198-5206, Nov 2024. [Impact Factor: 1.1]
    4. Singhal S, Dutta SB, Bansal S, Dutta S, Shah RB. Zinc as An Emerging Therapy in the Management of Migraine: A Systematic Review. Neurol India. 2024 Sep 1;72(5):934-942. doi: 10.4103/neurol-india.Neurol-India-D-23-00337. Epub 2024 Oct 19. PMID: 39428763. [Impact Factor: 0.9]
    5. Dutta S, Shah RB, Singhal S, Dutta SB, Bansal S, Sinha S, Haque M. Metformin's Enigma: Bridging Gaps in Research on Potential Benefits & Associated Risks - A Critical Plea for Comprehensive Investigation [Response to Letter]. Drug Des Devel Ther. 2024 Sep 7;18:4029-4031. doi: 10.2147/DDDT.S491638. PMID: 39268391; PMCID: PMC11390828. [Impact Factor: 4.7]
    6. Piparva KG, Dutta S, Singhal S, Shah R. A critical evaluation of contents, labeling, and cost of hand sanitizers marketed in India during COVID-19 pandemic. J Family Med Prim Care. 2024 Jun;13(6):2289-2294. [Impact Factor: 1.1]
    7. Singh M, Deokar K, Dutta S, Sinha BP, Katoch CDS. Impact of positive airway pressure therapy on intraocular pressure in obstructive sleep apnea: A systematic review. Eur J Ophthalmol. 2024 Apr 30:11206721241249502. [Impact Factor: 1.4]
    8. Dutta S, Singhal S, Shah R. A Systematic Analysis of COVID-19 Clinical Trials Registered in the Clinical Trials Registry of India. Cureus. 2024 Apr 9;16(4):e57939.
    9. Mishra AK, Dutta S. Mitophagy and Aging; In Mani S, Wasnik S, editors. Mitophagy and Its Role in Health and Disease Series: Cell Biology Research Progress; New York (USA), Nova Science Publishers, 2024. BISAC: SCI049000; SCI003000. DOI: https://doi.org/10.52305/ZKBP1526
    10. P. Guha, S. Dutta, K. Murti et al. The Integration of Omics: A Promising Approach to Personalized Tuberculosis Treatment, Medicine in Omics(2024), 100033, ISSN 2590-1249. doi: https://doi.org/10.1016/j.meomic.2024.100033
    11. Dutta S, Shah R, Singhal S, Singh S, Piparva K, Katoch CDS. A systematic review and meta-analysis of tolerability, cardiac safety and efficacy of inclisiran for the therapy of hyperlipidemic patients. Expert Opin Drug Saf. 2023 Dec 8:1-12. doi: 10.1080/14740338.2023.2293201. Epub ahead of print. PMID: 38063346. [Impact Factor: 3.1]
    12. Bhardwaj P, Ganapathy K, Pathania M, Naveen KH, Charan J, Dutta S, et al. Effectiveness of ayurvedic formulation, NAOQ19 along with standard care in the treatment of mild-moderate COVID-19 patients: A double blind, randomized, placebo-controlled, multicentric trial. J Ayurveda Integr Med. 2023 Nov 14;14(6):100778. doi: 10.1016/j.jaim.2023.100778. Epub ahead of print. PMID: 37976809; PMCID: PMC10684801.
    13. Dholariya S, Dutta S, Singh R, Parchwani D, Sonagra A, Kaliya M. Bexagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, for improvement of glycemia in type 2 diabetes mellitus: a systematic review and meta-analysis. Expert Opin Pharmacother. 2023 Oct 10:1-12. doi: 10.1080/14656566.2023.2269854. Epub ahead of print. PMID: 37817422[Impact Factor: 3.2]
    14. Dutta S, Singhal S, Shah R, Charan J, Dhingra S, Haque M. Daridorexant as a novel pharmacotherapeutic approach in insomnia: a systematic review and meta-analysis. Expert Opin Drug Saf. 2023 Aug 7:1-15. [Impact Factor: 3.1]
    15. Dutta S, Shah RB, Singhal S, Dutta SB, Bansal S, Sinha S, Haque M. Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes. Drug Des Devel Ther. 2023 Jun 26;17:1907-1932. [Impact Factor: 4.8]
    16. Singhal S, Shah RB, Piparva KG, Dutta S. Are we providing complete drug information to its users? Status of information adequacy of package insert in India. J Family Med Prim Care. 2023 Jul;12(7):1399-1405[Impact Factor: 1.4]
    17. Singhal S, Dutta S, Thakker Z, Shah R. Indian Essential Medicine List for Children: Time to Revisit. Cureus. 2023 Feb 22;15(2):e35340.
    18. Dutta S, Singhal S, Shah RB, Haque M. Immunotherapy and Targeted Therapy in the Management of Oral Cancers. Critical Reviews™ in Oncogenesis. 2022;27(4).
    19. Chowdhury K, Ahmad R, Sinha S, Dutta S, Haque M. Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now. Cureus. 2023 Feb 18;15(2):e35154.
    20. Dholariya S, Parchwani D, Dutta S, Singh R. Clinical efficacy and safety of dasiglucagon in severe hypoglycemia associated with patients of type 1 diabetes mellitus: a systematic review and meta-analysis. Expert Rev Clin Pharmacol. 2022 Oct 25:1-11. doi: 10.1080/17512433.2023.2138343. Epub ahead of print. PMID: 36266088. [Impact Factor: 4.1]
    21. Kamal ZM, Dutta S, Rahman S, Etando A, Hasan E, Nahar SN, Wan Ahmad Fakuradzi WFS, Sinha S, Haque M, Ahmad R. Therapeutic Application of Lithium in Bipolar Disorders: A Brief Review. Cureus. 2022 Sep 19;14(9):e29332.
    22. Sharma A, Kumar P, Dutta S. et al. Pathophysiological and Genetic Basis of Tenofovir-Induced Acute Renal Dysfunction: Strategies and Recent Developments for Better Clinical Outcomes. Curr Pharmacol Rep (2022). Doi: https://doi.org/10.1007/s40495-022-00304-w
    23. Umar BU, Rahman S, Dutta S, et al. Management of Atopic Dermatitis: The Role of Tacrolimus. Cureus. 2022 Aug 18;14(8):e28130
    24. Aswini S, Anil A, Dutta G, Sharma RP, Dutta S, Kumar T, Rajendran V, Singh S. Tomato Flu - A Review on Existing Scenario. Int. J. Pharm. Sci. Rev. Res. 2022;75(2): 196-199
    25. Dutta G, Anil A, Aswini S, Dutta S, Lal H, Kumar T. Infodemics: A Challenge to Public Health. Int. J. Pharm. Sci. Rev. Res. 2022; 4(2): 180-183
    26. Kumar R, Misra AK, Dutta S, Gupta A, Kumar B, Charan J. A systematic review of mucormycosis cases inCOVID‑19: Is it an unholy trilogy of COVID‑19, diabetes mellitus, and corticosteroids? Family Med Prim Care 2022;11:2573‑80.
    27. Goyal JP, Singh S, Bishnoi R, Bhardwaj P, Kaur RJ, Dhingra S, Yadav D, Dutta S, Charan J. Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2022 May 10:1-11. [Impact Factor: 5.09]
    28. Haque M, Ara T, Haq MA, Lugova H, Dutta S, Samad N, et al. Antimicrobial Prescribing Confidence and Knowledge Regarding Drug Resistance: Perception of Medical Students in Malaysia and the Implications. Antibiotics. 2022; 11(5):540. [Impact Factor: 4.63]
    29. Rabiu Abubakar A, Ahmad R, Rowaiye AB, Rahman S, Iskandar K, Dutta S, et al. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm. Life. 2022 Mar 25;12(4):478. [Impact Factor: 3.81]
    30. Dutta S, Mishra G, Lal H, Kumar T, Ram K, Ambwani S. Anxiety and wellbeing among healthcare workers during COVID-19 Pandemic. Int. J. Pharm. Sci. Rev. Res. 2022; 73(1): 114-119
    31. Dutta S, Kumar T, Singh S, Ambwani S, Charan J, Varthya SB. Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis. J Family Med Prim Care. 2022 Mar;11(3):927-940.
    32. Dutta S, Kaur RJ, Bhardwaj P, Ambwani S, Godman B, Jha PA, et al. Demand of COVID-19 medicines without prescription among community pharmacies in Jodhpur, India: Findings and implications. J Family Med Prim Care. 2022 Feb;11(2):503-511.
    33. Dutta S, Kaur R, Charan J, et al. Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines. Cureus 2022; 14(1): e21376. doi:10.7759/cureus.21376
    34. Dutta S, Vegada B, Tank ND et al. Assessment of Medical Students’ Perception Regarding Educational Environment at Different Phases of Medical Education in a Tertiary Centre Medical College using Dundee Ready Educational Environment Measure (DREEM) Questionnaire. Int. J. Pharm. Sci. Rev. Res. 2022; 72(1): 63-72
    35. Dutta S, Rahman S, Ahmad R, Kumar T, Dutta G, Banerjee S, Abubakar AR, Rowaiye AB, Dhingra S, Ravichandiran V, Kumar S, Sharma P, Haque M, Charan J. An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia. Expert Rev Neurother. 2021 Dec;21(12):1455-1472. [Impact Factor: 4.61]
    36. Ambwani S, Dutta S, Mishra G, Lal H, Singh S, Charan J. Adverse Drug Reactions Associated With Drugs Prescribed in Psychiatry: A Retrospective Descriptive Analysis in a Tertiary Care Hospital. Cureus. 2021 Nov 12;13(11):e19493.
    37. Bhardwaj P, Ganapathy K, Pathania M, Naveen KH, Charan J, Dutta S et al. An integrative approach to clinical recovery for COVID-19 patients using an Ayurvedic formulation: A multicentric double-blind randomized control trial. Research Square; 2021. DOI: 10.21203/rs.3.rs-1165680/v1.
    38. Singh S, Dutta S, Khasbage S, Kumar T, Sachin J, Sharma J, Varthya SB. A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis. Osteoporos Int. 2021 Aug 25. doi: 10.1007/s00198-021-06095-y. [Impact Factor: 4.50]
    39. Dutta S, Lal H, Kumar T, Mishra G, Charan J, Ambwani S. Knowledge, Attitude, Practice among Healthcare Workers regarding COVID-19: An Online Questionnaire-based Study.  Int J Pharm Sci Rev Res 2021; 69(2):238-244
    40. Dutta S, Kaur RJ, Bhardwaj P, Sharma P, Ambwani S, Islam S, et al. Adverse events reported from the COVID-19 vaccines: A descriptive study based on the WHO database (VigiBase®). J Appl Pharm Sci, 2021; 11(08): 001–009
    41. Jeet Kaur R, Dutta S, Charan J, Bhardwaj P, Tandon A, Yadav D, et al. Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database. Int J Gen Med. 2021;14:3909-3927. [Impact Factor: 2.46]
    42. Charan J, Dutta S, Kaur R, Bhardwaj P, Sharma P, Ambwani S, et al. Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database. Expert Opin Drug Saf. 2021 Jun 28:1-12. [Impact Factor: 4.25]
    43. Godman B, Haque M, Kumar S, Islam S, Charan J, Akter F, Kurdi A, Allocati E, Bakar MA, Rahim SA, Sultana N, Deeba F, Halim Khan MA, Alam AM, Jahan I, Kamal ZM, Hasin H, Munzur-E-Murshid, Nahar S, Haque M, Dutta S, et al. Current utilisation patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future. Curr Med Res Opin. 2021 Jun 24:1. doi: 10.1080/03007995.2021.1946024. Epub ahead of print. PMID: 34166174. [Impact Factor: 2.58]
    44. Godman B, Haque M, Leong T, Allocati E, Kumar S, Islam S, Charan J, Akter F, Kurdi A, Vassalo C, Bakar MA, Rahim SA, Sultana N, Deeba F, Khan MAH, Alam ABMM, Jahan I, Kamal ZM, Hasin H, Munzur EM , Nahar S, Haque M, Dutta S et al. The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future. Front. public health. 2021 Jun;9:671961. doi: 10.3389/fpubh.2021.671961. [Impact factor: 3.70]
    45. Dutta S, Kaur R, Bhardwaj P, Deora S, Singh K, Ambwani S, Charan J, Abubakar A, Jahan I, Lugova H, Islam S, Haque M. Hydroxychloroquine as Therapeutic Option in COVID-19: Analysis of Suspected Cardiovascular Adverse Drug Events Reported in the VigiBase. Bangladesh j. med. sci. 2021;20(4):897-910.
    46. Kumar T, Sharma A, Dutta S, Sachin J, Dutta G, Sharma RP. A Concise Review of Immune System and Natural Immune Modulators. Int J Pharm Sci Rev Res 2021; 68(2):79-84 DOI: 10.47583/ijpsrr.2021.v68i02.012
    47. Samad N, Dutta S, Sodunke TE, Fairuz A, Sapkota A, Miftah ZF, Jahan I, Sharma P, Abubakar AR, Rowaiye AB, Oli AN, Charan J, Islam S, Haque M. Fat-Soluble Vitamins and the Current Global Pandemic of COVID-19: Evidence-Based Efficacy from Literature Review. J Inflamm Res. 2021 May 21;14:2091-2110. [Impact Factor: 6.92]
    48. Dutta S, Ambwani S, Mishra G, Lal H, Ram K, Kumar T. Pharmacovigilance in The Era Of Covid-19: A Concise Review Of The Current Scenario, Implications, And Challenges. International Int J App Pharm. 2021 May: 13(3): 1-4.
    49. Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res. 2021;14:1487-1510. [Impact Factor: 6.92]
    50. Abubakar A, Sani I, Malami S, Yaro A, Jahan I, Adnan N, Kumar S, Islam S, Dutta S, Charan J, Haque M.  Anxiety Disorders: Recent Global Approach to Neuro-pathogenesis, Drug Treatment, Cognitive Behavioral Therapy, and Their Implications. Bangladesh j. med. sci. 2021; 20(3): 487-503.
    51. Dutta S, Haque M. Taking Highly Palatable Food or Naively Consuming Fatal Toxic Diet. Bangladesh j. med. sci. 2021; 20(3): 478-482.
    52. Dutta S, Ambwani S, Lal H, Ram K, Mishra G, Kumar T, Varthya SB. A Response to "The Satisfaction Level of Undergraduate Medical and Nursing Students Regarding Distant Preclinical and Clinical Teaching Amidst COVID-19 Across India" [Response to Letter]. Adv Med Educ Pract. 2021 Apr 19;12:349-350.
    53. Jahan D, Peile E, Sheikh MA, Islam S, Parasnath S, Sharma P, Iskandar K, Dhingra S, Charan J, Hardcastle TC, Samad N, Chowdhury TS, Dutta S, Haque M. Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation. Expert Rev Anti Infect Ther. 2021 Apr 13:1-22. [Impact Factor: 5.09 ]
    54. Kaur RJ, Dutta S, Bhardwaj P, Charan J, Dhingra S, Mitra P, Singh K, Yadav D, Sharma P, Misra S. Adverse Events Reported from COVID-19 Vaccine Trials: A Systematic Review. Indian J Clin Biochem. 2021 Mar 27:1-13.
    55. Dutta S, Kaur RJ, Charan J, Bhardwaj P, Sharma P, Ambwani S et al. Serious adverse events reported from the COVID-19 vaccines: A descriptive study based on WHO database. medRxiv 2021.03.23.21253433
    56. Charan J, Saxena D, Chaudhri M, Dutta S, Kaur RJ, Bhardwaj P. Opinion of primary care physicians regarding prescription of generic drugs: A Cross-sectional study. J Family Med Prim Care. 2021 Mar;10(3):1390-1398.
    57. Samad N, Sodunke TE, Abubakar AR, Jahan I, Sharma P, Islam S, Dutta S, Haque M. The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic. J Inflamm Res. 2021 Feb 26;14:527-550. [Impact Factor: 6.92 ]
    58. Dutta S, Haque M. COVID-19: Questions of Antimicrobial Resistance. Bangladesh j. med. sci. 2021 20(2), 221-227.
    59. Dutta S, Ambwani S, Lal H, Ram K, Mishra G, Kumar T, Varthya SB. The Satisfaction Level of Undergraduate Medical and Nursing Students Regarding Distant Preclinical and Clinical Teaching Amidst COVID-19 Across India. Adv Med Educ Pract. 2021 Feb 2;12:113-122.
    60. Haque M, Kumar S, Charan J, Bhatt R, Islam S, Dutta S, Abhayanand JP, Sharma Y, Sefah I, Kurdi A, Wale J, Godman B. Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications. Front Pharmacol. 2021 Jan 14;11:582154. [Impact Factor: 5.8]
    61. Charan J, Bhardwaj P, Dutta S, Kaur R, Bist KS, Detha M, et al. Use of Complementary and Alternative Medicine (CAM) and Home Remedies by COVID-19 Patients: A Telephonic Survey. Indian J Clin Biochem. 2021 Jan; 36(1): 108–111.
    62. Dutta S, Tayal V. Contraception and Drugs Used in Gynaecology. In: Mukhopadhaya N, Pundir J, Arora M, editors. Part 1 MRCOG Revision Notes and Sample SBAs. Cambridge: Cambridge University Press; 2020. p. 341–6.
    63. Godman B, Haque M, Islam S, Iqbal S, Urmi UL, Kamal ZM, Shuvo SA, Rahman A, Kamal M, Haque M, Jahan I, Islam MZ, Hossain MM, Munzur-E-Murshid, Kumar S, Charan J, Bhatt R, Dutta S, Abhayanand JP, Sharma Y, Saleem Z, Phuong TNT, Kwon HY, Kurdi A, Wale J, Sefah I. Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future. Front Public Health. 2020 Dec 14;8:585832. [Impact Factor: 3.70]
    64. Dutta S, Kaur RJ, Bhardwaj P, Charan J, Bist SKS, Detha MD, Kanchan T, Sharma P, Misra S. Household Transmission of COVID-19: A Cross-Sectional Study. Infect Drug Resist. 2020;13:4637-4642. [ Impact Factor: 4.00]
    65. Kaur RJ, Charan J, Dutta S, Sharma P, Bhardwaj P, Sharma P, Lugova H, Krishnapillai A, Islam S, Haque M, Misra S. Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database. Infect Drug Resist. 2020;13:4427-4438. [ Impact Factor: 4.00]
    66. Dutta S, Kaur R, Haque M, Bhardwaj P, Saxena D, Rahman NAA, Lugova H, Jahan D, Islam S, Chowdhury TS, Charan J. Terminated Interventional Trials in the Clinical Trial Registry of India Database: An Analysis to Evaluate the Reasons for Termination. Open Access J. Clin. Trials. 2020;12:61-70
    67. Charan J, Saxena D, Chaudhari M, Dutta S, Kaur RJ, Bhardwaj P. Opinion of patients seeking primary care regarding prescription of generic drugs: A cross-sectional study. J Family Med Prim Care 2020;9:5725-30
    68. Sharma RP, Dutta S, Kumar T, Mishra G, Lal H, Sharma A. An Overview on Infection Prevention and Control Practices and Biomedical Waste Management (BMWM) In Covid-19 Era. Int J Curr Pharm Res Nov 2020;12(6):5-8.
    69. Sharma RP, Dutta S, Kumar T, Singh S, Sharma A. Role of Alcohol Based Hand Rubs (ABHR) in the Covid-19 Era: A Concise Review. Int. J. Pharm. Sci. Rev. Res. Oct 2020; 64(1): 179-182.
    70. Lal H, Dutta S, Kumar T, Ram K. A Concise Review of Existing Therapies and Recent Advances in the Management of HIV Infection. Int. J. Pharm. Sci. Rev. Res. Oct 2020; 64(1):153-158.
    71. Dutta G, Kumar T, Dutta S, Kumar R, Banerjee S. Off-Label Prescribing: A Curse or A Boon. Int J Pharm Sci Rev Res. Oct 2020; 64(2):123-126.
    72. Kumar T, Dutta S, Sahai R, Khasbage S, Kumar R, Banerjee S. Dermatological Manifestations of COVID-19: A Review Based on Existing Reports. Int J Cur Res Rev. Jul 2020; 12(13): 65-68
    73. Sahai R, Dutta S, Kumar T. Anticoagulants in Covid-19 Therapy: An Evidence-Based Review. Int J Pharm Sci Rev Res.Jul 2020; 63(1):191-195
    74. Dutta S, Sharma P, Mishra A. SGLT-2 Inhibitors: An Evidence-Based Perspective. In: Atta-ur-Rahman, Editor. Frontiers in Clinical Drug Research-Diabetes and Obesity. Vol 5; Bentham Science Publishers, Sharjah: U.A.E. 2020. Pp. 138-155
    75. Dutta S. Nature as an answer to cancer: A review on natural anticancer. Int J Pharm Bio Sci 2020; 11(2):1-8. DOI: http://dx.doi.org/10.22376/ijpbs.2020.11.2.p1-8
    76. Dutta S. Calcitonin Gene-related Peptide Inhibitors: A Shift in Paradigm in the Therapy of Migraine. Int J Pharm Sci Rev Res 2019; 57(1): 78-83. Available from: https://globalresearchonline.net/journalcontents/v57-1/11.pdf
    77. Banerjee S, Arora S, John G, Dutta S, Kalra R, Sapra R. Effectiveness of a self-instructional module on knowledge, attitude, and practice regarding pharmacovigilance among staff nurses. Curr. Med. Res. Pract. 2019 Jun; 9(3):93-97.
    78. Kumar R, Misra AK, Dutta S, Sharma PK. Role of Cannabis in Diabetic Neuropathy: Is This the Therapeutic Agent? Int J Pharm Sci Rev Res 2019 Apr; 55(2):60 – 63. Available from: https://globalresearchonline.net/journalcontents/v55-2/11.pdf
    79. Sahai R, Sharma P, Mishra A, Dutta S. Pharmacology of the Therapeutic Approaches of Gout. In: Kurose R, Editor. Recent Advances in Gout. London, United Kingdom: IntechOpen. 2019. DOI: 10.5772/intechopen.85717
    80. Dutta S, Banerjee S, Kumar S, Jain A. Reverse Pharmacology: A Science Redefining Drug Discovery. European j. biomed. pharm.2019;6(3): 245-249
    81. Dutta S. Rational Use of Medicines: A Review. World j. pharm. Med. 2019;5(3): 129-132
    82. Dutta S, Banerjee S. Rheumatic Fever: A Review on Pathogenesis, Modified Diagnosis and Pharmacotherapy. Res. Rev. J. Med. Health Sci. Jan 2019; 8(1): 4-9.
    83. Dutta S, Chawla S, Srivastava S, Loomba P, Roy V. Prevalence of impaired renal function in patients of liver cirrhosis with or without spontaneous bacterial peritonitis. J. Drug Deliv. Ther.. 2019; 9(1-s):286-289
    84. Kumar S, Chawla S, Dutta S. Biobetters: Betting on the Future. J Rational Pharmacother Res 2018; 4(2):13-21.
    85. Dutta S, Sharma PK, Misra AK, Kumar R, Rai S, Chaudhary R. A Case Report on Warfarin Induced Skin Necrosis: Drug-drug Interaction or Inappropriate Therapy. J Pharm Sci Therap, 2018;4(1):230-233. DOI: https://doi.org/10.18314/jpt.v4i1.1445
    86. Dutta S. Pharmacovigilance in India: Evolution and Change in Scenario in India. Int. J. Sci. Res. 2018;7(10): 976 - 978. DOI:10.21275/ART20192070
    87. Dutta S, Chawla S, Srivastava S, Loomba P. Spontaneous Bacterial Peritonitis: A Review. Int J Curr Pharm Res 2018; 4(11A):3872-3876. 
    88. Dutta S, Chawla S and Banerjee S. Pharmacovigilance in India: A Need of the Hour.   Acta Sci. Med. Sci.2018; 2(8): 98-100.
    89. Dutta S, Chawla S, Kumar S. Psoriasis: A Review of Existing Therapies and Recent Advances in Treatment. J Rational Pharmacother Res 2018; 4 (1):12-23.
    90. Dutta S, Chawla S, Srivastava S., Loomba P, Roy V. Effect of trimethoprim-sulfamethoxazole vs. norfloxacin on fecal E. coli resistance pattern and efficacy in patients receiving prophylaxis for spontaneous bacterial peritonitis. Int J Basic Clin Pharmacol. 2018; 7(11): 2209-2215.
    91. Kumar S, Chawla S, Bimba HV, Rana P, Dutta S, Kumar S. Analysis of Prescribing Pattern and Techniques of Switching Over of Antipsychotics in Outpatients of a Tertiary Care Hospital in Delhi: A Prospective, Observational Study. J Basic Clin Pharma 2017;8: 178-184

     

    1. Publications (Book Chapters):-

     

    1. Dutta S, Sharma P, Mishra A. SGLT-2 Inhibitors: An Evidence-Based Perspective. In: Atta-ur-Rahman, Editor. Frontiers in Clinical Drug Research-Diabetes and Obesity. Vol 5; Bentham Science Publishers, Sharjah: U.A.E. 2020. Pp. 138-155
    2. Sahai R, Sharma P, Mishra A, Dutta S. Pharmacology of the Therapeutic Approaches of Gout. In: Kurose R, Editor. Recent Advances in Gout. London, United Kingdom: IntechOpen. 2019. DOI: 10.5772/intechopen.85717
    3. Dutta S, Tayal V. Contraception and Drugs Used in Gynaecology. In: Mukhopadhaya N, Pundir J, Arora M, editors. Part 1 MRCOG Revision Notes and Sample SBAs. Cambridge: Cambridge University Press; 2020. p. 341–6.
    4. Mishra AK, Dutta S. Mitophagy and Aging; In Mani S, Wasnik S, editors. Mitophagy and Its Role in Health and Disease Series: Cell Biology Research Progress; New York (USA), Nova Science Publishers, 2024. BISAC: SCI049000; SCI003000. DOI: https://doi.org/10.52305/ZKBP1526


     

    1. Awards/Honours Received:
    • Awarded Gold Medal for securing highest marks in DNB Pharmacology at National level by the National Board of Examinations in Medical Sciences (NBEMS)
    • First prize for oral presentation in faculty category in National Conference of the National Association of Pharmacology & Therapeutics 2024
    • National Award for Excellence in Research for publications with highest impact factor awarded by National Conference of the National Association of Pharmacology & Therapeutics 2024
    • Felicitated as a speaker in a workshop on “Good Clinical Practice- current regulatory and ethical requirements for conducting clinical trials/research in India” conducted by Department of Pharmacology, Andhra Medical College, Visakhapatnam, Andhra Pradesh

     

    1. Areas of interest:

    Clinical research, Clinical Pharmacology, Pharmacovigilance, Materiovigilance, Pharmacoepidemiology, Cardiometabolic disorders

     

    1. Membership of professional/academic/research bodies:
    1. Member of National Academy of Medical Sciences (MNAMS)
    2. Life Member of National Medicos Organization
    3. Life Member of Association of Physiologist and Pharmacologist of India (APPI)
    4. Life Member of National Association of Pharmacology & Therapeutics
    5. Life Member of Indian Pharmacological Society

     

    1. Research profile:

    ResearchGate profile: https://www.researchgate.net/profile/Siddhartha-Dutta-2/stats

    ORCID id: https://orcid.org/0000-0001-6525-5950

     

    1. Membership of professional/academic/research bodies:
    1. Member of National Academy of Medical Sciences (MNAMS)
    2. Member of National Medicos Organization
    3. Association of Physiologist and Pharmacologist of India (APPI)